melanocytes Search Results


99
ATCC normal human epidermal melanocytes
Normal Human Epidermal Melanocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human epidermal melanocytes/product/ATCC
Average 99 stars, based on 1 article reviews
normal human epidermal melanocytes - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

95
PromoCell melanocyte growth medium
Melanocyte Growth Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/melanocyte growth medium/product/PromoCell
Average 95 stars, based on 1 article reviews
melanocyte growth medium - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

93
Elabscience Biotechnology human α msh elisa
Human α Msh Elisa, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human α msh elisa/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
human α msh elisa - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

91
PromoCell melanocyte basal medium
Piece of amniotic membrane (a); immunohistochemistry for HMB-45 applied to cells cultured on slide. A large number of <t>melanocytes</t> can be observed (b); micrograph of cross-sectioned AM stained with HMB-45 after cell culture (c). Original magnification: (b, c) X100.
Melanocyte Basal Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/melanocyte basal medium/product/PromoCell
Average 91 stars, based on 1 article reviews
melanocyte basal medium - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

94
Proteintech cited1 polyclonal antibody
( A ) Heatmap of differentially expressed genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc or TFE3-S-Myc for 30 h. ( B ) Relative quantitative RT-PCR analysis of the mRNA expression of the indicated genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Control (Null) for 30 h. Data are presented as mean ± SD of three independent experiments. ACP5 ( ***(a) P = 0.0001; (ns) not significant (b) P = 0.7598; ****(c) P < 0.0001; ***(d) P = 0.0003; (ns) not significant (e) P = 0.709; ***(f) P = 0.0001), CHI3L1 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.1499; ****(c) P < 0.0001; ****(d) P < 0.0001; **(e) P = 0.0011; ****(f) P < 0.0001), ITGAX ( ***(a) P = 0.0004; (ns) not significant (b) P = 0.1892; ***(c) P = 0.0003; **(d) P = 0.004; (ns) not significant (e) P = 0.9899; **(f) P = 0.0028), SNHG15 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.7576; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P = 0.2091; ****(f) P < 0.0001), TFE3 ( ****(a) P < 0.0001; ****(b) P < 0.0001; ****(c) P < 0.0001; *(d) P = 0.0108; (ns) not significant (e) P = 0.1693; (ns) not significant (f) P = 0.2653) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( C ) Immunoblot analysis of protein lysates from ARPE19 cells infected with the indicated adenovirus for 30 h. Asterisk (*) indicates unspecific band. ( D ) Quantification of protein levels showing CD11c/GAPDH or YKL-40/GAPDH ratios expressed as fold change as shown in ( C ). Data are presented as mean ± SD of three independent experiments. (ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P = 0.9986; ****(d) P < 0.0001 (one-way ANOVA followed by Dunnett’s multiple comparison post-test). ( E ) Immunofluorescence confocal microscopy of ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Control for 30 h, showing the cellular distribution of YKL-40 (green). Scale bars: 10 μm. ( F ) Relative quantitative RT-PCR analysis of the mRNA expression of transcription regulator genes ( <t>CITED1</t> and C/EBPα ) in ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Ad-Null for 30 h. Data are presented as mean ± SD of three independent experiments. CITED1 ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001), C/EBPα ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( G ) Immunoblot analysis of protein lysates from ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Ad-Null for 30 h. ( H ) Quantification of protein levels showing CITED1/GAPDH, LAMP1/GAPDH, C/EBPα-p42/GAPDH, C/EBPα-p30/GAPDH, and LC3-II/LC3-I ratios expressed as fold change as shown in ( G ). Data are presented as mean ± SD of three independent experiments. CITED1 ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ****(d) P < 0.0001), C/EBPα (p42) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0002 ), LAMP1 ((ns) not significant (a) P = 0.956; *(b) P = 0.0127; **(c) P = 0.0023; **(d) P = 0.0044), C/EBPα (p30) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0001), LC3 ((ns) not significant (a) P = 0.8551; ****(b) P < 0.0001; ***(c) P = 0.0009; ****(d) P < 0.0001) (one-way ANOVA followed by Dunnett’s multiple comparison post-test). .
Cited1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cited1 polyclonal antibody/product/Proteintech
Average 94 stars, based on 1 article reviews
cited1 polyclonal antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Proteintech monoclonal antibodies against silv pmel17
( A ) Heatmap of differentially expressed genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc or TFE3-S-Myc for 30 h. ( B ) Relative quantitative RT-PCR analysis of the mRNA expression of the indicated genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Control (Null) for 30 h. Data are presented as mean ± SD of three independent experiments. ACP5 ( ***(a) P = 0.0001; (ns) not significant (b) P = 0.7598; ****(c) P < 0.0001; ***(d) P = 0.0003; (ns) not significant (e) P = 0.709; ***(f) P = 0.0001), CHI3L1 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.1499; ****(c) P < 0.0001; ****(d) P < 0.0001; **(e) P = 0.0011; ****(f) P < 0.0001), ITGAX ( ***(a) P = 0.0004; (ns) not significant (b) P = 0.1892; ***(c) P = 0.0003; **(d) P = 0.004; (ns) not significant (e) P = 0.9899; **(f) P = 0.0028), SNHG15 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.7576; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P = 0.2091; ****(f) P < 0.0001), TFE3 ( ****(a) P < 0.0001; ****(b) P < 0.0001; ****(c) P < 0.0001; *(d) P = 0.0108; (ns) not significant (e) P = 0.1693; (ns) not significant (f) P = 0.2653) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( C ) Immunoblot analysis of protein lysates from ARPE19 cells infected with the indicated adenovirus for 30 h. Asterisk (*) indicates unspecific band. ( D ) Quantification of protein levels showing CD11c/GAPDH or YKL-40/GAPDH ratios expressed as fold change as shown in ( C ). Data are presented as mean ± SD of three independent experiments. (ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P = 0.9986; ****(d) P < 0.0001 (one-way ANOVA followed by Dunnett’s multiple comparison post-test). ( E ) Immunofluorescence confocal microscopy of ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Control for 30 h, showing the cellular distribution of YKL-40 (green). Scale bars: 10 μm. ( F ) Relative quantitative RT-PCR analysis of the mRNA expression of transcription regulator genes ( <t>CITED1</t> and C/EBPα ) in ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Ad-Null for 30 h. Data are presented as mean ± SD of three independent experiments. CITED1 ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001), C/EBPα ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( G ) Immunoblot analysis of protein lysates from ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Ad-Null for 30 h. ( H ) Quantification of protein levels showing CITED1/GAPDH, LAMP1/GAPDH, C/EBPα-p42/GAPDH, C/EBPα-p30/GAPDH, and LC3-II/LC3-I ratios expressed as fold change as shown in ( G ). Data are presented as mean ± SD of three independent experiments. CITED1 ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ****(d) P < 0.0001), C/EBPα (p42) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0002 ), LAMP1 ((ns) not significant (a) P = 0.956; *(b) P = 0.0127; **(c) P = 0.0023; **(d) P = 0.0044), C/EBPα (p30) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0001), LC3 ((ns) not significant (a) P = 0.8551; ****(b) P < 0.0001; ***(c) P = 0.0009; ****(d) P < 0.0001) (one-way ANOVA followed by Dunnett’s multiple comparison post-test). .
Monoclonal Antibodies Against Silv Pmel17, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibodies against silv pmel17/product/Proteintech
Average 93 stars, based on 1 article reviews
monoclonal antibodies against silv pmel17 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

95
ATCC adult melanocyte growth kit
( A ) Heatmap of differentially expressed genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc or TFE3-S-Myc for 30 h. ( B ) Relative quantitative RT-PCR analysis of the mRNA expression of the indicated genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Control (Null) for 30 h. Data are presented as mean ± SD of three independent experiments. ACP5 ( ***(a) P = 0.0001; (ns) not significant (b) P = 0.7598; ****(c) P < 0.0001; ***(d) P = 0.0003; (ns) not significant (e) P = 0.709; ***(f) P = 0.0001), CHI3L1 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.1499; ****(c) P < 0.0001; ****(d) P < 0.0001; **(e) P = 0.0011; ****(f) P < 0.0001), ITGAX ( ***(a) P = 0.0004; (ns) not significant (b) P = 0.1892; ***(c) P = 0.0003; **(d) P = 0.004; (ns) not significant (e) P = 0.9899; **(f) P = 0.0028), SNHG15 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.7576; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P = 0.2091; ****(f) P < 0.0001), TFE3 ( ****(a) P < 0.0001; ****(b) P < 0.0001; ****(c) P < 0.0001; *(d) P = 0.0108; (ns) not significant (e) P = 0.1693; (ns) not significant (f) P = 0.2653) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( C ) Immunoblot analysis of protein lysates from ARPE19 cells infected with the indicated adenovirus for 30 h. Asterisk (*) indicates unspecific band. ( D ) Quantification of protein levels showing CD11c/GAPDH or YKL-40/GAPDH ratios expressed as fold change as shown in ( C ). Data are presented as mean ± SD of three independent experiments. (ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P = 0.9986; ****(d) P < 0.0001 (one-way ANOVA followed by Dunnett’s multiple comparison post-test). ( E ) Immunofluorescence confocal microscopy of ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Control for 30 h, showing the cellular distribution of YKL-40 (green). Scale bars: 10 μm. ( F ) Relative quantitative RT-PCR analysis of the mRNA expression of transcription regulator genes ( <t>CITED1</t> and C/EBPα ) in ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Ad-Null for 30 h. Data are presented as mean ± SD of three independent experiments. CITED1 ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001), C/EBPα ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( G ) Immunoblot analysis of protein lysates from ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Ad-Null for 30 h. ( H ) Quantification of protein levels showing CITED1/GAPDH, LAMP1/GAPDH, C/EBPα-p42/GAPDH, C/EBPα-p30/GAPDH, and LC3-II/LC3-I ratios expressed as fold change as shown in ( G ). Data are presented as mean ± SD of three independent experiments. CITED1 ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ****(d) P < 0.0001), C/EBPα (p42) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0002 ), LAMP1 ((ns) not significant (a) P = 0.956; *(b) P = 0.0127; **(c) P = 0.0023; **(d) P = 0.0044), C/EBPα (p30) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0001), LC3 ((ns) not significant (a) P = 0.8551; ****(b) P < 0.0001; ***(c) P = 0.0009; ****(d) P < 0.0001) (one-way ANOVA followed by Dunnett’s multiple comparison post-test). .
Adult Melanocyte Growth Kit, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adult melanocyte growth kit/product/ATCC
Average 95 stars, based on 1 article reviews
adult melanocyte growth kit - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

94
ATCC melanocyte growth kit
( A ) Heatmap of differentially expressed genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc or TFE3-S-Myc for 30 h. ( B ) Relative quantitative RT-PCR analysis of the mRNA expression of the indicated genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Control (Null) for 30 h. Data are presented as mean ± SD of three independent experiments. ACP5 ( ***(a) P = 0.0001; (ns) not significant (b) P = 0.7598; ****(c) P < 0.0001; ***(d) P = 0.0003; (ns) not significant (e) P = 0.709; ***(f) P = 0.0001), CHI3L1 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.1499; ****(c) P < 0.0001; ****(d) P < 0.0001; **(e) P = 0.0011; ****(f) P < 0.0001), ITGAX ( ***(a) P = 0.0004; (ns) not significant (b) P = 0.1892; ***(c) P = 0.0003; **(d) P = 0.004; (ns) not significant (e) P = 0.9899; **(f) P = 0.0028), SNHG15 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.7576; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P = 0.2091; ****(f) P < 0.0001), TFE3 ( ****(a) P < 0.0001; ****(b) P < 0.0001; ****(c) P < 0.0001; *(d) P = 0.0108; (ns) not significant (e) P = 0.1693; (ns) not significant (f) P = 0.2653) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( C ) Immunoblot analysis of protein lysates from ARPE19 cells infected with the indicated adenovirus for 30 h. Asterisk (*) indicates unspecific band. ( D ) Quantification of protein levels showing CD11c/GAPDH or YKL-40/GAPDH ratios expressed as fold change as shown in ( C ). Data are presented as mean ± SD of three independent experiments. (ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P = 0.9986; ****(d) P < 0.0001 (one-way ANOVA followed by Dunnett’s multiple comparison post-test). ( E ) Immunofluorescence confocal microscopy of ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Control for 30 h, showing the cellular distribution of YKL-40 (green). Scale bars: 10 μm. ( F ) Relative quantitative RT-PCR analysis of the mRNA expression of transcription regulator genes ( <t>CITED1</t> and C/EBPα ) in ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Ad-Null for 30 h. Data are presented as mean ± SD of three independent experiments. CITED1 ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001), C/EBPα ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( G ) Immunoblot analysis of protein lysates from ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Ad-Null for 30 h. ( H ) Quantification of protein levels showing CITED1/GAPDH, LAMP1/GAPDH, C/EBPα-p42/GAPDH, C/EBPα-p30/GAPDH, and LC3-II/LC3-I ratios expressed as fold change as shown in ( G ). Data are presented as mean ± SD of three independent experiments. CITED1 ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ****(d) P < 0.0001), C/EBPα (p42) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0002 ), LAMP1 ((ns) not significant (a) P = 0.956; *(b) P = 0.0127; **(c) P = 0.0023; **(d) P = 0.0044), C/EBPα (p30) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0001), LC3 ((ns) not significant (a) P = 0.8551; ****(b) P < 0.0001; ***(c) P = 0.0009; ****(d) P < 0.0001) (one-way ANOVA followed by Dunnett’s multiple comparison post-test). .
Melanocyte Growth Kit, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/melanocyte growth kit/product/ATCC
Average 94 stars, based on 1 article reviews
melanocyte growth kit - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec igg1 pe cd56 vio bright b515 miltenyi biotec
( A ) Heatmap of differentially expressed genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc or TFE3-S-Myc for 30 h. ( B ) Relative quantitative RT-PCR analysis of the mRNA expression of the indicated genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Control (Null) for 30 h. Data are presented as mean ± SD of three independent experiments. ACP5 ( ***(a) P = 0.0001; (ns) not significant (b) P = 0.7598; ****(c) P < 0.0001; ***(d) P = 0.0003; (ns) not significant (e) P = 0.709; ***(f) P = 0.0001), CHI3L1 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.1499; ****(c) P < 0.0001; ****(d) P < 0.0001; **(e) P = 0.0011; ****(f) P < 0.0001), ITGAX ( ***(a) P = 0.0004; (ns) not significant (b) P = 0.1892; ***(c) P = 0.0003; **(d) P = 0.004; (ns) not significant (e) P = 0.9899; **(f) P = 0.0028), SNHG15 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.7576; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P = 0.2091; ****(f) P < 0.0001), TFE3 ( ****(a) P < 0.0001; ****(b) P < 0.0001; ****(c) P < 0.0001; *(d) P = 0.0108; (ns) not significant (e) P = 0.1693; (ns) not significant (f) P = 0.2653) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( C ) Immunoblot analysis of protein lysates from ARPE19 cells infected with the indicated adenovirus for 30 h. Asterisk (*) indicates unspecific band. ( D ) Quantification of protein levels showing CD11c/GAPDH or YKL-40/GAPDH ratios expressed as fold change as shown in ( C ). Data are presented as mean ± SD of three independent experiments. (ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P = 0.9986; ****(d) P < 0.0001 (one-way ANOVA followed by Dunnett’s multiple comparison post-test). ( E ) Immunofluorescence confocal microscopy of ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Control for 30 h, showing the cellular distribution of YKL-40 (green). Scale bars: 10 μm. ( F ) Relative quantitative RT-PCR analysis of the mRNA expression of transcription regulator genes ( <t>CITED1</t> and C/EBPα ) in ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Ad-Null for 30 h. Data are presented as mean ± SD of three independent experiments. CITED1 ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001), C/EBPα ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( G ) Immunoblot analysis of protein lysates from ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Ad-Null for 30 h. ( H ) Quantification of protein levels showing CITED1/GAPDH, LAMP1/GAPDH, C/EBPα-p42/GAPDH, C/EBPα-p30/GAPDH, and LC3-II/LC3-I ratios expressed as fold change as shown in ( G ). Data are presented as mean ± SD of three independent experiments. CITED1 ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ****(d) P < 0.0001), C/EBPα (p42) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0002 ), LAMP1 ((ns) not significant (a) P = 0.956; *(b) P = 0.0127; **(c) P = 0.0023; **(d) P = 0.0044), C/EBPα (p30) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0001), LC3 ((ns) not significant (a) P = 0.8551; ****(b) P < 0.0001; ***(c) P = 0.0009; ****(d) P < 0.0001) (one-way ANOVA followed by Dunnett’s multiple comparison post-test). .
Igg1 Pe Cd56 Vio Bright B515 Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igg1 pe cd56 vio bright b515 miltenyi biotec/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
igg1 pe cd56 vio bright b515 miltenyi biotec - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
PromoCell culture reagents primary human epidermal melanocytes
The top 5 highest represented GO terms of differentially expressed genes (DEGs) in NHEM-c <t> melanocytes </t> treated with melanoma A375 exo versus those with control 0 exo using CATEGORY COMPARE.
Culture Reagents Primary Human Epidermal Melanocytes, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/culture reagents primary human epidermal melanocytes/product/PromoCell
Average 94 stars, based on 1 article reviews
culture reagents primary human epidermal melanocytes - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
ATCC neonatal
The top 5 highest represented GO terms of differentially expressed genes (DEGs) in NHEM-c <t> melanocytes </t> treated with melanoma A375 exo versus those with control 0 exo using CATEGORY COMPARE.
Neonatal, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neonatal/product/ATCC
Average 94 stars, based on 1 article reviews
neonatal - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

Image Search Results


Piece of amniotic membrane (a); immunohistochemistry for HMB-45 applied to cells cultured on slide. A large number of melanocytes can be observed (b); micrograph of cross-sectioned AM stained with HMB-45 after cell culture (c). Original magnification: (b, c) X100.

Journal: Dermatology Research and Practice

Article Title: Amniotic Membrane as a Scaffold for Melanocyte Transplantation in Patients with Stable Vitiligo

doi: 10.1155/2011/532139

Figure Lengend Snippet: Piece of amniotic membrane (a); immunohistochemistry for HMB-45 applied to cells cultured on slide. A large number of melanocytes can be observed (b); micrograph of cross-sectioned AM stained with HMB-45 after cell culture (c). Original magnification: (b, c) X100.

Article Snippet: Melanocyte basal medium (MBM, PromoCell, Heidelberg, Germany) without PMA (phorbol 12-myristate 13-acetate) nor bovine pituitary extract, supplemented with basic fibroblast growth factor (1 ng/mL), human recombinant stem cell factor (50 ng/mL), and human recombinant granulocyte/macrophage colony-stimulating factor (10 ng/mL) for 10–14 days, was used for the melanocyte culture.

Techniques: Membrane, Immunohistochemistry, Cell Culture, Staining

Patient 1. Preoperatively (a); the achromic epidermis was removed using CO 2 laser, and AM carrying cultured melanocytes on the basement membrane surface was applied on the denuded area with one layer of Vaseline gauze. The amniotic membranes were fixed with steri-strips and covered with dry gauze and adhesive tape (b); postoperative photography (>90% repigmentation at 16 weeks) (c).

Journal: Dermatology Research and Practice

Article Title: Amniotic Membrane as a Scaffold for Melanocyte Transplantation in Patients with Stable Vitiligo

doi: 10.1155/2011/532139

Figure Lengend Snippet: Patient 1. Preoperatively (a); the achromic epidermis was removed using CO 2 laser, and AM carrying cultured melanocytes on the basement membrane surface was applied on the denuded area with one layer of Vaseline gauze. The amniotic membranes were fixed with steri-strips and covered with dry gauze and adhesive tape (b); postoperative photography (>90% repigmentation at 16 weeks) (c).

Article Snippet: Melanocyte basal medium (MBM, PromoCell, Heidelberg, Germany) without PMA (phorbol 12-myristate 13-acetate) nor bovine pituitary extract, supplemented with basic fibroblast growth factor (1 ng/mL), human recombinant stem cell factor (50 ng/mL), and human recombinant granulocyte/macrophage colony-stimulating factor (10 ng/mL) for 10–14 days, was used for the melanocyte culture.

Techniques: Cell Culture, Membrane, Adhesive

( A ) Heatmap of differentially expressed genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc or TFE3-S-Myc for 30 h. ( B ) Relative quantitative RT-PCR analysis of the mRNA expression of the indicated genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Control (Null) for 30 h. Data are presented as mean ± SD of three independent experiments. ACP5 ( ***(a) P = 0.0001; (ns) not significant (b) P = 0.7598; ****(c) P < 0.0001; ***(d) P = 0.0003; (ns) not significant (e) P = 0.709; ***(f) P = 0.0001), CHI3L1 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.1499; ****(c) P < 0.0001; ****(d) P < 0.0001; **(e) P = 0.0011; ****(f) P < 0.0001), ITGAX ( ***(a) P = 0.0004; (ns) not significant (b) P = 0.1892; ***(c) P = 0.0003; **(d) P = 0.004; (ns) not significant (e) P = 0.9899; **(f) P = 0.0028), SNHG15 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.7576; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P = 0.2091; ****(f) P < 0.0001), TFE3 ( ****(a) P < 0.0001; ****(b) P < 0.0001; ****(c) P < 0.0001; *(d) P = 0.0108; (ns) not significant (e) P = 0.1693; (ns) not significant (f) P = 0.2653) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( C ) Immunoblot analysis of protein lysates from ARPE19 cells infected with the indicated adenovirus for 30 h. Asterisk (*) indicates unspecific band. ( D ) Quantification of protein levels showing CD11c/GAPDH or YKL-40/GAPDH ratios expressed as fold change as shown in ( C ). Data are presented as mean ± SD of three independent experiments. (ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P = 0.9986; ****(d) P < 0.0001 (one-way ANOVA followed by Dunnett’s multiple comparison post-test). ( E ) Immunofluorescence confocal microscopy of ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Control for 30 h, showing the cellular distribution of YKL-40 (green). Scale bars: 10 μm. ( F ) Relative quantitative RT-PCR analysis of the mRNA expression of transcription regulator genes ( CITED1 and C/EBPα ) in ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Ad-Null for 30 h. Data are presented as mean ± SD of three independent experiments. CITED1 ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001), C/EBPα ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( G ) Immunoblot analysis of protein lysates from ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Ad-Null for 30 h. ( H ) Quantification of protein levels showing CITED1/GAPDH, LAMP1/GAPDH, C/EBPα-p42/GAPDH, C/EBPα-p30/GAPDH, and LC3-II/LC3-I ratios expressed as fold change as shown in ( G ). Data are presented as mean ± SD of three independent experiments. CITED1 ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ****(d) P < 0.0001), C/EBPα (p42) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0002 ), LAMP1 ((ns) not significant (a) P = 0.956; *(b) P = 0.0127; **(c) P = 0.0023; **(d) P = 0.0044), C/EBPα (p30) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0001), LC3 ((ns) not significant (a) P = 0.8551; ****(b) P < 0.0001; ***(c) P = 0.0009; ****(d) P < 0.0001) (one-way ANOVA followed by Dunnett’s multiple comparison post-test). .

Journal: EMBO Reports

Article Title: Differential contribution of TFE3 isoforms to cell motility and invasion

doi: 10.1038/s44319-025-00659-3

Figure Lengend Snippet: ( A ) Heatmap of differentially expressed genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc or TFE3-S-Myc for 30 h. ( B ) Relative quantitative RT-PCR analysis of the mRNA expression of the indicated genes in ARPE19 cells infected with either adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Control (Null) for 30 h. Data are presented as mean ± SD of three independent experiments. ACP5 ( ***(a) P = 0.0001; (ns) not significant (b) P = 0.7598; ****(c) P < 0.0001; ***(d) P = 0.0003; (ns) not significant (e) P = 0.709; ***(f) P = 0.0001), CHI3L1 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.1499; ****(c) P < 0.0001; ****(d) P < 0.0001; **(e) P = 0.0011; ****(f) P < 0.0001), ITGAX ( ***(a) P = 0.0004; (ns) not significant (b) P = 0.1892; ***(c) P = 0.0003; **(d) P = 0.004; (ns) not significant (e) P = 0.9899; **(f) P = 0.0028), SNHG15 ( ****(a) P < 0.0001; (ns) not significant (b) P = 0.7576; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P = 0.2091; ****(f) P < 0.0001), TFE3 ( ****(a) P < 0.0001; ****(b) P < 0.0001; ****(c) P < 0.0001; *(d) P = 0.0108; (ns) not significant (e) P = 0.1693; (ns) not significant (f) P = 0.2653) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( C ) Immunoblot analysis of protein lysates from ARPE19 cells infected with the indicated adenovirus for 30 h. Asterisk (*) indicates unspecific band. ( D ) Quantification of protein levels showing CD11c/GAPDH or YKL-40/GAPDH ratios expressed as fold change as shown in ( C ). Data are presented as mean ± SD of three independent experiments. (ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P = 0.9986; ****(d) P < 0.0001 (one-way ANOVA followed by Dunnett’s multiple comparison post-test). ( E ) Immunofluorescence confocal microscopy of ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Control for 30 h, showing the cellular distribution of YKL-40 (green). Scale bars: 10 μm. ( F ) Relative quantitative RT-PCR analysis of the mRNA expression of transcription regulator genes ( CITED1 and C/EBPα ) in ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc or Ad-Null for 30 h. Data are presented as mean ± SD of three independent experiments. CITED1 ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001), C/EBPα ( ***(a) P < 0.0001; (ns) not significant (b) P = 0.1888; ****(c) P < 0.0001; ****(d) P < 0.0001; (ns) not significant (e) P > 0.9999; ****(f) P < 0.0001) (one-way ANOVA followed by Tukey’s multiple comparison post-test). ( G ) Immunoblot analysis of protein lysates from ARPE19 cells infected with adenovirus expressing recombinant TFE3-L-Myc, TFE3-S-Myc, TFE3-L/M106A-Myc, or Ad-Null for 30 h. ( H ) Quantification of protein levels showing CITED1/GAPDH, LAMP1/GAPDH, C/EBPα-p42/GAPDH, C/EBPα-p30/GAPDH, and LC3-II/LC3-I ratios expressed as fold change as shown in ( G ). Data are presented as mean ± SD of three independent experiments. CITED1 ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ****(d) P < 0.0001), C/EBPα (p42) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0002 ), LAMP1 ((ns) not significant (a) P = 0.956; *(b) P = 0.0127; **(c) P = 0.0023; **(d) P = 0.0044), C/EBPα (p30) ((ns) not significant (a) P > 0.9999; ****(b) P < 0.0001; (ns) not significant (c) P > 0.9999; ***(d) P = 0.0001), LC3 ((ns) not significant (a) P = 0.8551; ****(b) P < 0.0001; ***(c) P = 0.0009; ****(d) P < 0.0001) (one-way ANOVA followed by Dunnett’s multiple comparison post-test). .

Article Snippet: CITED1 Polyclonal antibody , Proteintech , Cat# 26999-1-AP, RRID:AB_2296838.

Techniques: Infection, Expressing, Recombinant, Quantitative RT-PCR, Control, Comparison, Western Blot, Immunofluorescence, Confocal Microscopy

The top 5 highest represented GO terms of differentially expressed genes (DEGs) in NHEM-c  melanocytes  treated with melanoma A375 exo versus those with control 0 exo using CATEGORY COMPARE.

Journal: Experimental cell research

Article Title: Comparative gene expression analysis in melanocytes driven by tumor cell-derived exosomes

doi: 10.1016/j.yexcr.2019.111690

Figure Lengend Snippet: The top 5 highest represented GO terms of differentially expressed genes (DEGs) in NHEM-c melanocytes treated with melanoma A375 exo versus those with control 0 exo using CATEGORY COMPARE.

Article Snippet: Cell lines and culture reagents Primary human epidermal melanocytes, NHEM-c cells, were purchased from PromoCell (Heidelberg, Germany).

Techniques: Control, Chemotaxis Assay

The top 5 highest represented KEGG pathways in NHEM-c  melanocytes  treated with melanoma A375 exo versus those with control 0 exo using CATEGORY COMPARE.

Journal: Experimental cell research

Article Title: Comparative gene expression analysis in melanocytes driven by tumor cell-derived exosomes

doi: 10.1016/j.yexcr.2019.111690

Figure Lengend Snippet: The top 5 highest represented KEGG pathways in NHEM-c melanocytes treated with melanoma A375 exo versus those with control 0 exo using CATEGORY COMPARE.

Article Snippet: Cell lines and culture reagents Primary human epidermal melanocytes, NHEM-c cells, were purchased from PromoCell (Heidelberg, Germany).

Techniques: Control

Western blot to confirm CXCL2 protein expression. Protein extracts (50ug) from NHEM-c cells treated with melanocyte NHEM-c exo or melanoma A375exo were assessed using the antibody against CXCL2. HSC70 was used as a loading control.

Journal: Experimental cell research

Article Title: Comparative gene expression analysis in melanocytes driven by tumor cell-derived exosomes

doi: 10.1016/j.yexcr.2019.111690

Figure Lengend Snippet: Western blot to confirm CXCL2 protein expression. Protein extracts (50ug) from NHEM-c cells treated with melanocyte NHEM-c exo or melanoma A375exo were assessed using the antibody against CXCL2. HSC70 was used as a loading control.

Article Snippet: Cell lines and culture reagents Primary human epidermal melanocytes, NHEM-c cells, were purchased from PromoCell (Heidelberg, Germany).

Techniques: Western Blot, Expressing, Control

Top 5 enriched GO terms of DEGs in NHEM-c  melanocytes  by melanoma A375exo and lung cancer A549exo versus Control 0 exo using CATEGORY COMPARE.

Journal: Experimental cell research

Article Title: Comparative gene expression analysis in melanocytes driven by tumor cell-derived exosomes

doi: 10.1016/j.yexcr.2019.111690

Figure Lengend Snippet: Top 5 enriched GO terms of DEGs in NHEM-c melanocytes by melanoma A375exo and lung cancer A549exo versus Control 0 exo using CATEGORY COMPARE.

Article Snippet: Cell lines and culture reagents Primary human epidermal melanocytes, NHEM-c cells, were purchased from PromoCell (Heidelberg, Germany).

Techniques: Control

Top 5 enriched KEGG pathways of DEGs in NHEM-c  melanocytes  by melanoma A375exo and lung cancer A549exo versus Control 0 exo using CATEGORY COMPARE.

Journal: Experimental cell research

Article Title: Comparative gene expression analysis in melanocytes driven by tumor cell-derived exosomes

doi: 10.1016/j.yexcr.2019.111690

Figure Lengend Snippet: Top 5 enriched KEGG pathways of DEGs in NHEM-c melanocytes by melanoma A375exo and lung cancer A549exo versus Control 0 exo using CATEGORY COMPARE.

Article Snippet: Cell lines and culture reagents Primary human epidermal melanocytes, NHEM-c cells, were purchased from PromoCell (Heidelberg, Germany).

Techniques: Control